Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Hims & Hers Health (HIMS) surged after Novo Nordisk A/S was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform.

- Live Nation Entertainment (LYV) shares rise after Politico reported that the company reached a settlement with the Department of Justice in its antitrust case and will pay $200 million in damages to participating states.

- Aureus Greenway Holdings (AGH) says AGH and Autonomous Power entered into a definitive agreement to merge into an entity that focuses on drone industry and autonomous systems innovation.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Hims &amp; Hers Health (HIMS) surged after Novo Nordisk A/S was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform.
- Live Nation Entertainment (LYV) shares rise after Politico reported that the company reached a settlement with the Department of Justice in its antitrust case and will pay $200 million in damages to participating states.
- Aureus Greenway Holdings (AGH) says AGH and Autonomous Power entered into a definitive agreement to merge into an entity that focuses on drone industry and autonomous systems innovation.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Hims & Hers Surges on Novo Obesity Deal; Live Nation Rises; Powerus & Aureus Greenway to Merge

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/23b0f5fc-1d32-46fd-a8a2-b40800d7ef6b/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Griefeld, Carol Massar and Norah Mulinda

- Hims & Hers (HIMS) shares rallyed Monday after Novo said it had agreed to sell its Ozempic and Wegovy injectables, as well as an oral version of Wegovy, through Hims' online pharmacy. Hims surged 38% to $21.75, putting the stock on track for its largest single-day percentage increase on record, according to Dow Jones Market Data. Novo's U.S.-listed shares advanced 1.9% against a 0.6% decline for the benchmark S&P 500.

- Uber (UBER) and DoorDash (DASH) shares sank today after oil prices continued to rise due to the conflicts in the Middle East.

- Warner Bros. Discovery (WBD) is the target of a $110 billion acquisition by Paramount Skydance (PSKY) in which Tencent plans to invest several hundred million dollars as a passive financial backer, Bloomberg News reported Monday, citing unnamed people familiar with the situation. Wells Fargo set Paramount Skydance's ratings at underweight, with a price target of $10. Shares of Paramount Skydance dropped 8%, with intraday trading volume at over 7.8 million versus a daily average of roughly 10.6 million.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Griefeld, Carol Massar and Norah Mulinda - Hims &amp; Hers (HIMS) shares rallyed Monday after Novo said it had agreed to sell its Ozempic and Wegovy injectables, as well as an oral version of Wegovy, through Hims' online pharmacy. Hims surged 38% to $21.75, putting the stock on track for its largest single-day percentage increase on record, according to Dow Jones Market Data. Novo's U.S.-listed shares advanced 1.9% against a 0.6% decline for the benchmark S&amp;P 500. - Uber (UBER) and DoorDash (DASH) shares sank today after oil prices continued to rise due to the conflicts in the Middle East. - Warner Bros. Discovery (WBD) is the target of a $110 billion acquisition by Paramount Skydance (PSKY) in which Tencent plans to invest several hundred million dollars as a passive financial backer, Bloomberg News reported Monday, citing unnamed people familiar with the situation. Wells Fargo set Paramount Skydance's ratings at underweight, with a price target of $10. Shares of Paramount Skydance dropped 8%, with intraday trading volume at over 7.8 million versus a daily average of roughly 10.6 million.

Closing Bell: HIMS Surges, Uber & DoorDash Sinks, Paramount Drops

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/87366428-b688-412b-bebe-b408014c2472/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Uber (UBER) and DoorDash (DASH) shares sank today after oil prices continued to rise due to the conflicts in the Middle East.

- Hims & Hers Health (HIMS) surged after Bloomberg News reported that Novo Nordisk A/S (NOVOB DC) plans to sell its weight-loss drugs on the telehealth company’s platform, ending a public feud between the two companies.

- Live Nation (LYV) stocks climbed after the company and its Ticketmaster subsidiary reached a settlement with federal antitrust authorities.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Uber (UBER) and DoorDash (DASH) shares sank today after oil prices continued to rise due to the conflicts in the Middle East. - Hims &amp; Hers Health (HIMS) surged after Bloomberg News reported that Novo Nordisk A/S (NOVOB DC) plans to sell its weight-loss drugs on the telehealth company&rsquo;s platform, ending a public feud between the two companies. - Live Nation (LYV) stocks climbed after the company and its Ticketmaster subsidiary reached a settlement with federal antitrust authorities.

Uber, DoorDash Sink; Hims & Hers, Live Nation Surge

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/857848e2-2484-4e86-b913-b40801395a3c/transcript

On this episode of Stock Movers:

- Him & Hers (HIMS) shares surge after Novo Nordisk was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform. Novo and Hims plan to announce a new partnership as soon as Monday, according to a person familiar with the matter, who spoke on the condition of anonymity.

- Live Nation Entertainment (LYV) shares rise. Live Nation Entertainment Inc. and its Ticketmaster subsidiary have reached a settlement with federal antitrust authorities, according to the Justice Department. The agreement was announced with no details provided, but it would reportedly open parts of Live Nation's ticketing arm to third-party sellers and make it easier for other promoters to put on shows at amphitheaters that Live Nation controls.

- Brown-Forman (BF/B) shares fall after Bernstein analyst Nadine Sarwat cut her recommendation on the alcohol beverage company to market perform from outperform. “This rating change isn’t about the structural vs. cyclical debate in US alcohol or the risk of price wars (from the US ‘whiskey glut’ or competitors) — our views on this remain unchanged,” Sarwat writes.

On this episode of Stock Movers:

- Him & Hers (HIMS) shares surge after Novo Nordisk was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform. Novo and Hims plan to announce a new partnership as soon as Monday, according to a person familiar with the matter, who spoke on the condition of anonymity.

- Live Nation Entertainment (LYV) shares rise. Live Nation Entertainment Inc. and its Ticketmaster subsidiary have reached a settlement with federal antitrust authorities, according to the Justice Department. The agreement was announced with no details provided, but it would reportedly open parts of Live Nation's ticketing arm to third-party sellers and make it easier for other promoters to put on shows at amphitheaters that Live Nation controls.

- Brown-Forman (BF/B) shares fall after Bernstein analyst Nadine Sarwat cut her recommendation on the alcohol beverage company to market perform from outperform. “This rating change isn’t about the structural vs. cyclical debate in US alcohol or the risk of price wars (from the US ‘whiskey glut’ or competitors) — our views on this remain unchanged,” Sarwat writes.

On this episode of Stock Movers:
- Him &amp; Hers (HIMS) shares surge after Novo Nordisk was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform. Novo and Hims plan to announce a new partnership as soon as Monday, according to a person familiar with the matter, who spoke on the condition of anonymity.
- Live Nation Entertainment (LYV) shares rise. Live Nation Entertainment Inc. and its Ticketmaster subsidiary have reached a settlement with federal antitrust authorities, according to the Justice Department. The agreement was announced with no details provided, but it would reportedly open parts of Live Nation's ticketing arm to third-party sellers and make it easier for other promoters to put on shows at amphitheaters that Live Nation controls.
- Brown-Forman (BF/B) shares fall after Bernstein analyst Nadine Sarwat cut her recommendation on the alcohol beverage company to market perform from outperform. &ldquo;This rating change isn&rsquo;t about the structural vs. cyclical debate in US alcohol or the risk of price wars (from the US &lsquo;whiskey glut&rsquo; or competitors) &mdash; our views on this remain unchanged,&rdquo; Sarwat writes.
On this episode of Stock Movers:
- Him &amp; Hers (HIMS) shares surge after Novo Nordisk was said to have ended its public feud with the company with an agreement to sell its weight-loss drugs on the Hims platform. Novo and Hims plan to announce a new partnership as soon as Monday, according to a person familiar with the matter, who spoke on the condition of anonymity.
- Live Nation Entertainment (LYV) shares rise. Live Nation Entertainment Inc. and its Ticketmaster subsidiary have reached a settlement with federal antitrust authorities, according to the Justice Department. The agreement was announced with no details provided, but it would reportedly open parts of Live Nation's ticketing arm to third-party sellers and make it easier for other promoters to put on shows at amphitheaters that Live Nation controls.
- Brown-Forman (BF/B) shares fall after Bernstein analyst Nadine Sarwat cut her recommendation on the alcohol beverage company to market perform from outperform. &ldquo;This rating change isn&rsquo;t about the structural vs. cyclical debate in US alcohol or the risk of price wars (from the US &lsquo;whiskey glut&rsquo; or competitors) &mdash; our views on this remain unchanged,&rdquo; Sarwat writes.

Hims & Hers Health Surges, Live Nation Entertainment Rises, Brown-Forman Falls as Bernstein Downgrades on Costly Whiskey

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/94a655c3-d6c8-4c9a-86a2-b40800f9ff8c/transcript

Hims & Hers Surges on Novo Obesity Deal; Live Nation Rises; Powerus & Aureus Greenway to Merge

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips